This judgment addresses the question of whether the Irish State is entitled, as a matter of EU law, to prohibit the importation and sale of products which contain elements of the main psychoactive ingredient in cannabis. The essence of the Applicant’s case is that, provided that the quantity of this psychoactive ingredient present in the product falls below a certain threshold, the product does not constitute a “drug” or “narcotic” for the purpose of EU law. Rather, on the Applicant’s case, the product constitutes a conventional “good” subject to the principle of the free movement of goods under the Treaty on the Functioning of the European Union.